Authored By: Sarah
23 Jan 2025

Latest News- Emerging Molecular Diagnostics Market: PCR is expected to lead the Technology segment during 2025-2029

The Emerging Molecular Diagnostics Market is being driven by Prevalence of chronic diseases

The Emerging Molecular Diagnostics Market is expected to grow at a CAGR of 6.4% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 3801.3 million. The emerging molecular diagnostics market is experiencing robust growth, driven by continuous innovation and new product launches. In February 2023, Thermo Fisher Scientific, Inc. introduced the QuantStudio, a digital PCR research tool from Applied Biosystems, marking a significant advancement in digital PCR technology. The Absolute Q AutoRun dPCR Suite, also launched by Thermo Fisher Scientific, is anticipated to revolutionize molecular diagnostics with its improved precision, automation, and wide application range, from basic research to clinical diagnostics. This innovation is expected to enhance the accuracy and reliability of molecular diagnostic tools, significantly impacting the market landscape. 

Get more information on Emerging Molecular Diagnostics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on segments_for_ai.nslist

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

  • Prevalence of chronic diseases
  • Increasing global geriatric population
  • Rising prevalence of neurological disorders

However, the market also witnesses some limitations, which are as follows:

  • High cost associated with molecular diagnostics
  • Presence of stringent regulations
  • Availability of alternatives

Benefits of Buying Global Emerging Molecular Diagnostics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Emerging Molecular Diagnostics Market Research Report

Market Scope

Report Coverage

Details

Page number

206

Base year

2024

Historic period

2019-2023

Forecast period

2025-2029

Growth momentum & CAGR

Accelerate at a CAGR of 6.4%

Market growth 2025-2029

USD 3801.3 million

Market structure

Fragmented

YoY growth 2024-2025(%)

5.0

Key countries

US, UK, Germany, China, Japan, Canada, India, South Korea, Australia, and Mexico

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Emerging Molecular Diagnostics Market encompasses advancements in patient monitoring through personalized medicine, medical research, and clinical diagnostics. Healthcare technology innovations include point-of-care diagnostics, clinical trials, disease prevention, and drug development. Genetic testing services, gene sequencing, and early disease detection play a significant role. Biomarker discovery and biotechnology advancements, such as DNA sequencing technology and liquid biopsy, are driving precision medicine. The biotechnology industry focuses on digital health, regulatory standards, and disease screening. Clinical decision support, laboratory automation, telemedicine, molecular TB testing, and services and software are essential components. Medical device development, wearable technology, and remote patient monitoring in home healthcare are also part of this dynamic market.

Market Research Overview

The global life sciences tools and services market encompasses companies and offerings involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, accessories, and consumables. These tools are utilized in the pharmaceutical and biotechnology sectors, as well as laboratory diagnosis of diverse disease areas. The market size is determined by Technavio through the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. Factors driving market growth include the increasing elderly population, with predictions of a significant increase in those aged 60 and above. Additionally, advancements in molecular diagnostics, including the identification of deletions and single nucleotide polymorphisms in genetic sequences, are fueling market expansion.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.


Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.